HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
PVLA
Palvella Therapeutics Inc
Healthcare Biotechnology · Massachusetts, USA · Reports in usd
Market Cap: $1.55B
Market Cap
$1.55B
Enterprise Val
$1.49B
P/E Ratio
-37.07
P/B Ratio
55.26
Trailing PEG (1Y)
0.04
As Of
Apr 21, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$28.0M
Return on Equity-98.14%
Return on Assets-59.66%
Current Ratio5.20
Debt/Equity0.02
LT Debt/Equity0.02
Revenue Per Share0.00

Income Statement

Dec 31, 2025
Revenue$0.00
Cost of Revenue$0.00
Gross Profit$0.00
R&D$7.1M
SG&A$4.2M
Operating Expenses$11.3M
Operating Income-$11.3M
Interest Expense$3.8M
Tax Expense$0.00
Net Income-$12.7M
EPS (Basic)$-1.08
EPS (Diluted)$-1.08
EBIT-$8.9M
EBITDA-$8.8M
Consolidated Income-$12.7M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$58.0M
Accounts Receivable$0.00
Inventory$0.00
Current Assets$59.0M
LT Investments$0.00
Property, Plant & Equipment$572.0K
Intangibles$0.00
Non-Current Assets$572.0K
Total Assets$59.6M
Accounts Payable$4.6M
Current Debt$202.0K
Current Liabilities$11.3M
LT Debt$431.0K
Non-Current Liabilities$20.2M
Total Liabilities$31.6M
Total Debt$633.0K
Retained Earnings-$135.5M
Shareholder Equity$28.0M
Shares Outstanding11,836,490

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow-$4.9M
Investing Cash Flow$0.00
Financing Cash Flow-$49.0K
CapEx$0.00
Free Cash Flow-$4.9M
Depreciation & Amort.$62.0K
Stock-Based Comp$2.1M
Acquisitions / Disposals$0.00
Investment Activity$0.00
Debt Issued/Repaid$0.00
Equity Issued/Repaid$105.0K
Dividends Paid$0.00
Net Change in Cash-$5.6M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h